关于超级生物可用伊特拉科纳的IADVL SIG反复性皮肤植物病的立场陈述
Nayankumar H Patel1, Kabir Sardana2, Manjunath M Shenoy3
1Department of DVL, GCS Medical College Hospital and Research Centre, Ahmedabad, Gujarat, India.
Indian dermatology online journal
|January 29, 2024
概括
超级生物可用伊特拉可纳可纳 (SUBA-ITZ) 为治疗反复性皮肤植物病 (RD) 提供了改善的药理动力学. 这份立场声明指导皮肤科医生如何有效和安全地使用SUBA-ITZ用于RD管理.
科学领域:
- 皮肤病学 皮肤病学
- 药理学 药理学是指药理学的学科.
- 菌类学 菌类学是指菌类学.
背景情况:
- 伊特拉科纳 (ITZ) 是一种主要的口服抗真菌药物,用于印度的复发性皮肤病 (RD).
- 现在可以使用一种新的超级生物可用配方 (SUBA-ITZ).
- 了解SUBA-ITZ的药理动力学对于安全有效的临床使用至关重要.
研究的目的:
- 审查有关 SUBA-ITZ. 的现有证据.
- 确定SUBA-ITZ在管理R&D方面的地位.
- 为皮肤科医生指导 SUBA-ITZ 的使用.
主要方法:
- 特别兴趣小组对反复性皮肤植物病 (SIG-RD) 的立场陈述的制定.
- 对SUBA-ITZ.Z.现有的科学文献和临床数据的审查.
- 专家达成共识,并制定建议.
主要成果:
- 与传统的ITZ配方相比,SUBA-ITZ显示了增强的生物利用性.
- 药物动力学数据支持潜在的提高疗效和安全性.
- 该SIG-RD提供了关于将SUBA-ITZ整合到RD治疗方案的指导.
结论:
- 苏巴-伊茨代表了口服抗真菌治疗RD的重大进步.
- 皮肤科医生应该考虑 SUBA-ITZ 在 RD 中改善患者的结果.
- 进一步的研究可能会阐明SUBA-ITZ的长期疗效和安全性.
更多相关视频
10:49Identification of Small Molecule-binding Proteins in a Native Cellular Environment by Live-cell Photoaffinity Labeling
Published on: September 20, 2016
12.7K
06:50A Soluble Tetrazolium-Based Reduction Assay to Evaluate the Effect of Antibodies on Candida tropicalis Biofilms
Published on: September 16, 2022
3.1K
相关概念视频
Skin Diseases and Disorders
3.9K
Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
3.9K
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
166
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
166
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
120
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
120
